Rexford Capital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Rexford Capital's NVS Position: Q3 2026 in Review
Rexford Capital reduced its Novartis (NVS) stake by 5.2% in Q3 2026, selling an estimated $39.6K and leaving 4,798 shares worth $684K. The position accounts for 0.43% of the portfolio, ranked #69.
Rexford Capital first reported a position in NVS in Q2 2025 and has held it in 6 quarters since. The position peaked at $793K in Q2 2026. 1,555 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Rexford Capital held 4,798 shares of Novartis worth $684K as of Q3 2026.
- Rexford Capital sold 261 Novartis shares in Q3 2026, an estimated $39.6K.
- Novartis made up 0.43% of Rexford Capital's portfolio in Q3 2026, its #69 holding.
- Rexford Capital first reported a position in Novartis in Q2 2025 and has held it in 6 quarters since.
- Rexford Capital's Novartis position peaked at $793K in Q2 2026.
- 1,555 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Rexford Capital's 13F filing for Q3 2026, filed 13 Nov 2026.